Table 3.
111In radioactivity in mouse tissues after intratumoral injection of 111In-NOTA-DTox-HMP-NLS-EGF into EJ human bladder cancer xenografts (percent ID per gram of tissue, mean ± standard deviation).
Time Tissue | 5 min | 1 h | 3 h | 1 day | 2 days | 5 days |
---|---|---|---|---|---|---|
Blood | 0.244 ± 0.046 | 0.318 ± 0.076 | 0.167 ± 0.010 | 0.062 ± 0.017 | 0.025 ± 0.001 | 0.017 ± 0.006 |
Tumor | 367 ± 101 | 370 ± 176 | 463 ± 123 | 566 ± 77 | 264 ± 79 | 80 ± 63 |
PT skin | 5.9 ± 7.8 | 46.9 ± 12.4 | 50.4 ± 24.7 | 58.0 ± 23.9 | 61.7 ± 4.0 | 49.0 ± 19.0 |
RLN | 40.5 ± 38.6 | 45.9 ± 57.1 | 73.6 ± 1.5 | 71.0 ± 7.3 | 67.0 ± 34.6 | 41.5 ± 22.4 |
Liver | 0.70 ± 0.60 | 1.18 ± 0.27 | 1.40 ± 0.55 | 1.65 ± 0.52 | 1.54 ± 0.40 | 1.33 ± 0.23 |
Kidney | 1.82 ± 0.97 | 13.3 ± 5.17 | 12.0 ± 1.12 | 12.1 ± 2.8 | 7.71 ± 1.99 | 3.07 ± 2.37 |
Lung | 0.30 ± 0.14 | 0.23 ± 0.10 | 0.135 ± 0.017 | 0.094 ± 0.004 | 0.063 ± 0.031 | 0.037 ± 0.016 |
Spleen | 0.25 ± 0.18 | 0.280 ± 0.092 | 0.43 ± 0.11 | 0.62 ± 0.28 | 0.57 ± 0.22 | 0.52 ± 0.13 |
Bones | 0.198 ± 0.028 | 1.19 ± 0.36 | 0.44 ± 0.18 | 0.578 ± 0.071 | 0.55 ± 0.47 | 0.43 ± 0.31 |
Bladder | 0.260 ± 0.13 | 0.196 ± 0.073 | 0.253 ± 0.083 | 0.074 ± 0.013 | 0.051 ± 0.038 | 0.041 ± 0.021 |
Stomach | 0.29 ± 0.10 | 0.35 ± 0.23 | 0.213 ± 0.008 | 0.140 ± 0.076 | 0.080 ± 0.031 | 0.075 ± 0.052 |
Intestine | 0.134 ± 0.041 | 0.203 ± 0.098 | 0.255 ± 0.092 | 0.125 ± 0.017 | 0.093 ± 0.012 | 0.053 ± 0.043 |
Heart | 0.21 ± 0.13 | 0.155 ± 0.076 | 0.083 ± 0.006 | 0.090 ± 0.026 | 0.059 ± 0.008 | 0.023 ± 0.012 |
Muscles | 0.32 ± 0.29 | 0.34 ± 0.23 | 0.246 ± 0.078 | 0.206 ± 0.064 | 0.20 ± 0.15 | 0.168 ± 0.045 |
Skin | 0.079 ± 0.019 | 0.610 ± 0.057 | 0.180 ± 0.071 | 0.325 ± 0.049 | 0.205 ± 0.021 | 0.225 ± 0.064 |
PT, peritumoral skin samples; RLN, regional lymph node.